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DoR Communicator
Researchers exchange ideas and meet prospective collaborators
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With more than 400 funded researchers spread across two campuses and
three centers, including FIU Downtown on Brickell and the Miami Beach
Urban Studios, it can be difficult to
learn about the university's research
efforts—even those that are in one's
particular specialty. But one of DoR's
top priorities in the next few years is
to build interdisciplinary research and
to promote integration and support
integration of ideas. The best way to
accomplish this initiative is to introduce the researchers to each other and
let them form new relationships within
and without their areas of interest.
On October 18, FIU scholars and researchers met with the vice president
for research, Andrés G. Gil, and senior
leadership within DoR to exchange
ideas on increasing research funding
as well as meet prospective collaborators. It was a unique opportunity for
the faculty to network with their peers
in a non-academic setting. There are
so many talented research faculty at
FIU that the event will be held again at
a later date to accommodate more researchers.

From left to right, Leonard Scinto (assistant professor,
SEAS), Andrés Gil (vice president for research), and
Fernando Noriega (professor, biology)

Luis Salas, associate vice president for research,
discusses research development and funding
opportunities with Lindsay Malloy, assistant
professor of psychology

Assistant professor of psychology Lindsay Malloy was happy to meet faculty
outside her department to discuss possible collaborations. “The DoR reception
was an excellent opportunity to chat
with faculty outside my department, to
learn about the exciting research that
they are working on currently, and to
find out about how they funded it,” said
Malloy. Additionally, she was able to
find others who can guide her—“as
soon as I mentioned an interest in applying for a NSF Career proposal, I was
immediately introduced to someone
who had received one in the past and
others who had great advice on preparing one! This was a very valuable opportunity, and I appreciated the chance
to spend an afternoon getting to know so
many accomplished people who were
willing to share their experiences and
advice.” Malloy is currently studying theoretical and practical questions
concerning children’s disclosure of negative experiences and children’s involvement in the legal system.
But after this event, look for Malloy to
be an investigator on other studies—
maybe even as an awardee on an NSF
Career proposal.

For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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Upcoming Events
November 2013

 November 1 at 9 am in EC 2300, “Ink-Jet Printing of Sol-Gel Derived Bioinks to Produce Bioactive Paper Sensors
for Environmental and Biomedical Analysis” by John D. Brennan from McMaster University, Ontario, Canada—part
of the Wallace H. Coulter Foundation BME Seminar Series.
 November 1 at 12 noon in AHC1 # 110 “The Impact of Social Withdrawal on Children’s Adjustment: Physiological
and Contextual Influences” by Heather Henderson—part of CCF’s Brown Bag Series.
 November 3 through 5: Society for the Study of Human Development 8th Biennial Meeting at Westin Beach Hotel
and Spa: “Rethinking Developmental Science across the Life-span/Life-course: Theory, Methods and Applications.”
http://sish.fiu.edu/events/2013/fort-lauderdale-society-for-the-study-of-human-development-conference/
 November 7 from 10 am to 12 noon in RDB 1000, the Center for Leadership presents Robert Schreiter. Please visit
http://lead.fiu.edu/engagement/lectureseries/leadership/index.html for registration details.
 November 8 at 9 am in EC 2300, “Coupled Multiscale Analysis of Bio and Nano–Mechanical Systems” by Vinu
Unnikrishnan from the University of Alabama—part of the Wallace H. Coulter Foundation BME Seminar Series.
 November 8 at 12 noon in ACH1 #110 “Extending the Scope and Accessibility of Children’s Mental Health Care
through Technology” by Jon Comer—part of CCF’s Brown Bag Series.
 November 12 at 10 am Ribbon Cutting Ceremony, Stocker AstroScience Center (President Emeritus Modesto
Maidique, Dean Ken Furton, and Special Guest Nobel laureate John Mather, with James Webb as emcee). Reception
to follow at 11 am.
 November 12 from 3:30 to 4:45 pm in AHC3 #110, “The History of the Universe from Beginning to End, and
Observing with the James Webb Space Telescope” a public lecture by Dr. John Mather, Nobel Laureate.
 November 12 at 8 pm Stocker AstroScience Star Party.
 November 13 in the MARC Pavilion—FIU’s annual Department of Energy (DOE) Induction Ceremony.
 November 14 from 1:30 to 2:30 pm in AHC4 #101, “Single Molecule Spectroscopy of Amino Acids and Peptides by
Recognition Tunneling” by Stuart Lindsay, Professor and Director, Center for Single Cell Molecule Biophysics
http://sish.fiu.edu/initiatives/biomolecular-and-biomedical/archived-lectures/
 November 15 at 12 noon in AHC1 #110 “Neurobiological Organization of Language: Research Using High-Field
Magnetic Resonance Imaging” by Anthony Dick—part of CCF’s Brown Bag Series.
 November 19 and 20 at the RDB College of Law Large Courtroom, the second annual industry meeting of the
National Science Foundation (NSF) Nanosystems Engineering Research Center (ERC) for Advanced Self-Powered
Systems of Integrated Sensors and Technologies (ASSIST). Please register here.
 November 20 at 9:45 am in the MARC Pavilion “Connecting Genomic Alterations to Cancer Biology with
Proteomics” presented by Dr. Henry Rodríguez, Director of the Office of Cancer Clinical Proteomics Research at the
National Cancer Institute, National Institutes of Health.
 November 22 at 11 am at the College of Business Complex Room 155 (and via polycom at BBC Marine Sciences
Building Room 105), “Accelerating and Enhancing the Drug Discovery Process” by Dr. Richard Houghten from
Torrey Pines Institute for Molecular Studies.
December 2013
 December 3 (by invitation only) Second Annual Induction Ceremony of the FIU Chapter of the National Academy of
Inventors.
 December 3 3:30 to 5pm in AHC-4 #402, “Preparing for the 3rd Year Review” by Meredith Newman, Sr. Associate
Dean (CAS)
 December 6 at 12 noon in AHC1 #110 “The Changing Landscape of Cannabis Use and Its Impact on Neurocognitive
Functioning” by Raúl González—part of CCF’s Brown Bag Series.
 December 10 at 3:30 pm in the MARC Pavilion “Developing Testable Hypotheses” by O. Dale Williams, FIU
Professor and Chair of the Biostatistics Department.

January 2014

 January 14 from 12 to 1:30 pm at the Faculty Club, “Faculty Mentor Lunch for CAS-CEC-RSCPHSW for
mentor/mentee pairs.”
 January 23 & 24 from 8 am to 5 pm at the MARC Pavilion, “2014 Workshop on Origami Design for Integration of
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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Self-assembling Systems for Engineering Innovation.”
 January 29 & 30 from 8:30 am to 5 pm at the MARC Pavilion, “Alcohol Research Center Annual Conference.”
The previously announced Team Science workshop has been moved to Spring 2014.

Awards Received—September 2013
Florida International University researchers were awarded $12,903,136 in September 2013. Below is a summary:
PI: Omar I Abdul Aziz
INTERNATIONAL HURRICANE CENTER
Award Action Type: Initial
AWARDING SPONSOR: Florida Office of Insurance Regulation
TITLE: Sub-Project: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm
Surge and Flooding 2013-2014
AWARD: $
133,098
PI: Malek Adjouadi
ELEC AND COMPUTER ENG
Award Action Type: Continuation
AWARDING SPONSOR: University of Texas El Paso
TITLE: BPC-AE: Computing Alliance of Hispanic-Serving Institutions (CAHSI) Renewal
AWARD: $
PI: Malek Adjouadi
ELEC AND COMPUTER ENG
Award Action Type: Continuation
AWARDING SPONSOR: University of Texas El Paso
TITLE: Participant payments: BPC-AE: Computing Alliance of Hispanic Serving Institutions (CAHSI) Renewal
AWARD: $
PI: Arvind Agarwal
MECHANICAL AND MAT ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: Clarkson Aerospace Corp
TITLE: AFRL Collaboration Program - Materials and Manufacturing Research
AWARD: $

36,892

19,000

73,000

PI: Heidi Alvarez
CIARA
Award Action Type: Continuation
AWARDING SPONSOR: University of Chicago
TITLE: Open Science Data Cloud(OSDC)PIRE:Training and Workshops

AWARD: $

115,411

PI: Heidi Alvarez
CIARA
Award Action Type: Continuation
AWARDING SPONSOR: University of Chicago
TITLE: Open Science Data Cloud(OSDC)PIRE:Training and Workshops

AWARD: $

45,000

PI: Ralf Arndt
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: University of Vermont
TITLE: Condition Assessment of the First Fort Bowie and Condition Assessment of the Second Fort Bowie, Fort Bowie
National Historic Site
AWARD: $
20,510

For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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PI: Shekhar Bhansali
ELEC AND COMPUTER ENG
Award Action Type: Pre-Award
AWARDING SPONSOR: North Carolina State University
TITLE: Advanced Self-Powered Systems of Integrated Sensor Technologies (ASSIST)

AWARD: $

49,606

PI: Shekhar Bhansali
ELEC AND COMPUTER ENG
Award Action Type: Pre-Award
AWARDING SPONSOR: North Carolina State University
TITLE: Participant Payments ASSIST

AWARD: $

7,200

PI: Shekhar Bhansali
ELEC AND COMPUTER ENG
Award Action Type: Pre-Award
AWARDING SPONSOR: North Carolina State University
TITLE: Participant Pmts Y2 ASSIST

AWARD: $

7,200

PI: Shekhar Bhansali
ELEC AND COMPUTER ENG
Award Action Type: Initial
AWARDING SPONSOR: Naval Research Laboratory
TITLE: Nanostructure Interaction Assessment of MCS Cells Using EIS Technique in a Microfluidic System
AWARD: $
100,000
PI: Eric Bishop-Von Wettberg
BIOLOGY
Award Action Type: Increase
AWARDING SPONSOR: Fairchild Tropical Botanic Garden
TITLE: Fairchild Tropical Botanic Garden supports research and education in tropical botany. As a tangible expression of
this support, they provide graduate student support for individuals working for higher degrees in areas of tropical plant
science.
AWARD: $
213
PI: Eric Bishop-Von Wettberg
BIOLOGY
Award Action Type: Initial
AWARDING SPONSOR: University of California Davis
TITLE: Deducing the genomic footprint and functional impact of chickpea domestication on nitrogen fixation
AWARD: $
PI: Eric Thomas Brewe
COE TEACHING AND LEARNING
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: INSPIRE Type 1: Investigating Retention and Persistence with Network Analysis
AWARD: $
PI: David Richard Brown
COM HUMANITIES HLTH AND SOC
Award Action Type: Initial
AWARDING SPONSOR: American Academy of Developmental Medicine
TITLE: FRIEND Project
AWARD: $
PI: Yong Cai
ARC APPLIED RESEARCH CENTER
Award Action Type: Increase
AWARDING SPONSOR: Office of Environmental Management
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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TITLE: Sub Project: Florida International University's Research Support to the Department of Energy's Office of
Environmental Management
AWARD: $

22,827

PI: Shu-Ching Chen
INTERNATIONAL HURRICANE CENTER
Award Action Type: Initial
AWARDING SPONSOR: Florida Office of Insurance Regulation
TITLE: Sub-Project: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm
Surge and Flooding 2013-2014
AWARD: $
153,678
PI: Jonathan Comer
CENTER FOR CHILDREN AND FAM
Award Action Type: Initial
AWARDING SPONSOR: National Institute of Mental Health
TITLE: Evaluating the Feasibility of Internet-Delivered Parent-Child Interaction Therapy

AWARD: $

28,192

PI: Carol E Damian
FROST ART MUSEUM
Award Action Type: Initial
AWARDING SPONSOR: Miami-Dade County Cultural Affairs
TITLE: FY 2013-2014 MCI Frost Art Museum

AWARD: $

24,575

PI: Jessy Devieux
HEALTH PROMO AND DISEASE PREV
Award Action Type: Initial
AWARDING SPONSOR: University of California Los Angeles
TITLE: Seed grant

AWARD: $

21,040

PI: Maureen Donnelly
BIOLOGY
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: Graduate Research Fellowship Program

AWARD: $

2,000

PI: Maria C Donoso
EARTH AND ENVIRONMENT
Award Action Type: Increase
AWARDING SPONSOR: US Agency for International Development
TITLE: West Africa Water Supply-Ghana

AWARD: $

1,903,254

PI: Maria C Donoso
EARTH AND ENVIRONMENT
Award Action Type: Increase
AWARDING SPONSOR: US Agency for International Development
TITLE: West Africa Water Supply-Niger

AWARD: $

484,482

PI: Maria-Rosa Drake
NETWORK SERVICES
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: FlowWaves: CC-NIE Networking Infrastructure: FlowWave: Enabling
High Bandwidth Science Data Flows

AWARD: $

275,908

For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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PI: James W Fourqurean
SOUTHEAST ENV RESEARCH CTR
Award Action Type: Continuation
AWARDING SPONSOR: National Park Service
TITLE: The South Florida Caribbean Inventory and Monitoring Network Undergraduate Internship and Training Program
AWARD: $
94,938
PI: James W Fourqurean
BIOLOGY
Award Action Type: Increase
AWARDING SPONSOR: University of Miami
TITLE: Aquarius Reef Base
AWARD: $
500,086
PI: Rebecca Friedman
SIPA
Award Action Type: Increase
AWARDING SPONSOR: European Commission
TITLE: Miami-Florida European Center of Excellence

AWARD: $

3,000

PI: Cheng-Tin Gan
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: Florida Department of Transportation
TITLE: Feasibility of a Web-Based System for Police Report Review and Information Recording
AWARD: $
90,000
PI: Stavros Georgakopoulos
ELEC AND COMPUTER ENG
Award Action Type: Initial
AWARDING SPONSOR: Georgia Institute of Technology
TITLE: EFRI-ODISSEI: Novel Perpetual Reconfigurable & Multi-Band "Origami Folding/Unfolding" Electromagnetic
Systems for Cognitive Intelligence Applications
AWARD: $
683,766
PI: Mohammed A Hadi
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: University of Florida
TITLE: STRIDE Internship-Amauris Ramirez

AWARD: $

7,427

PI: Shahid Hamid
INTERNATIONAL HURRICANE CENTER
Award Action Type: Initial
AWARDING SPONSOR: Florida Office of Insurance Regulation
TITLE: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm Surge and
Flooding 2013-2014
AWARD: $
833,253
PI: Shahid Hamid
INTERNATIONAL HURRICANE CENTER
Award Action Type: Increase
AWARDING SPONSOR: Florida Office of Insurance Regulation
TITLE: Sub-Contracts: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm
Surge and Flooding 2013-2014
AWARD: $
423,271
PI: Jin He
PHYSICS
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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TITLE: Carbon nanotube based nanofluidic device for biological sensing

AWARD: $

308,623

PI: Michael Heithaus
BIOLOGY
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: Graduate Research Fellowship Program

AWARD: $

2,000

PI: Michelle M Hospital
PSYCHOLOGY
Award Action Type: Initial
AWARDING SPONSOR: Ware Foundation
TITLE: Enhancing Resilience among At-Risk Minority Youth through Music Education: An Evaluation of ESMIA (aka,
Project TREBLE). Resilience among at Risk Minority Youth through Music Education: An Evaluation of ESMIA
AWARD: $
30,000
PI: Kenneth Arthur Jessell
DIVISION OF FINANCE AND ADMIN
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of Transportation
TITLE: UniversityCity Prosperity Project
AWARD: $
100,000
PI: Sylvan C Jolibois
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of Transportation
TITLE: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU

AWARD: $

5,000

PI: Sylvan C Jolibois
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of Transportation
TITLE: Mohammaafali 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU
AWARD: $
3,000
PI: Sylvan C Jolibois
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of Transportation
TITLE: Fakharian Qom '13 Felllowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU
AWARD: $
3,000
PI: Sylvan C Jolibois
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of Transportation
TITLE: Crean 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU
AWARD: $
10,000
PI: Sylvan C Jolibois
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of Transportation
TITLE: Johnson 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU
AWARD: $
7,500
PI: Sylvan C Jolibois
CIVIL AND ENVIRON ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of Transportation
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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TITLE: Edmonson 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU
AWARD: $
PI: Ranu Jung
BIOMEDICAL ENGINEERING
Award Action Type: Increase
AWARDING SPONSOR: FIU Foundation
TITLE: Cardiovascular Engineering Center Fund
AWARD: $

10,000

PI: Ranu Jung
BIOMEDICAL ENGINEERING
Award Action Type: Increase
AWARDING SPONSOR: FIU Foundation
TITLE: Biomedical Engineering Exercise Scholarship Fund

AWARD: $

12,500

PI: Leonel Lagos
ARC APPLIED RESEARCH CENTER
Award Action Type: Increase
AWARDING SPONSOR: Office of Environmental Management
TITLE: FIU's Research Support to Dept. of Energy's Office of Environmental Management

AWARD: $

271,215

PI: Leonel Lagos
ARC APPLIED RESEARCH CENTER
Award Action Type: Increase
AWARDING SPONSOR: Office of Environmental Management
TITLE: Sub Project 1: FIU's Research Support to Dept. of Energy's Office of Environmental Management
AWARD: $
PI: Leonel Lagos
ARC APPLIED RESEARCH CENTER
Award Action Type: Increase
AWARDING SPONSOR: Office of Environmental Management
TITLE: FIU's Research Support to Dept. of Energy's Office of Environmental Management
AWARD: $

256,343

5,000

114,496

PI: Leonel Lagos
ARC APPLIED RESEARCH CENTER
Award Action Type: Increase
AWARDING SPONSOR: Office of Environmental Management
TITLE: Sub Project 3- Remediation: FIU's Research Support to Dept. of Energy's Office of Environmental Management
AWARD: $
144,647
PI: Leonel Lagos
ARC APPLIED RESEARCH CENTER
Award Action Type: Increase
AWARDING SPONSOR: Office of Environmental Management
TITLE: Subproject -Waste and D&D Eng: FIU's Research Support to Dept. of Energy's Office of Environmental
Management
AWARD: $
278,618
PI: Chenzhong Li
BIOMEDICAL ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: SubProject: Carbon nanotube based nanofluidic device for biological sensing

AWARD: $

PI: Robert Lickliter
DOR - DIVISION OF RESEARCH
Award Action Type: Increase
AWARDING SPONSOR: General Medical Sciences
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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TITLE: FIU MBRS RISE - Administrative: MBRS Research Initiative for Scientific Enhancement
AWARD: $
PI: Robert Lickliter
DOR - DIVISION OF RESEARCH
Award Action Type: Increase
AWARDING SPONSOR: General Medical Sciences
TITLE: FIU MBRS RISE - Trainee: MBRS Research Initiative for Scientific Enhancement
AWARD: $
PI: Christine Lisetti
COMPUTER INFO SCIENCES
Award Action Type: Initial
AWARDING SPONSOR: Inst for Disabilities Rsrch & Training
TITLE: American Sign Language Literacy Support System
AWARD: $
PI: Hong Liu
EARTH AND ENVIRONMENT
Award Action Type: Increase
AWARDING SPONSOR: Fairchild Tropical Botanic Garden
TITLE: GA for the Fairchild Challenge educational program

AWARD: $

111,214

802,767

70,000

293

PI: Hong Liu
EARTH AND ENVIRONMENT
Award Action Type: Increase
AWARDING SPONSOR: Fairchild Tropical Botanic Garden
TITLE: Conservation ecology of selected plants in Halmahera, Indonesia Graduate Assistantship for Melissa Abdo
AWARD: $
188
PI: Lindsay Malloy
PSYCHOLOGY
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: Graduate Research Fellowship Program
AWARD: $
2,000
PI: Kalai Mathee-narasimhan
COM HUMAN AND MOL GENETICS
Award Action Type: Initial
AWARDING SPONSOR: FIU Division of Research
TITLE: BRIDGE Funding 13-14

AWARD: $

8,742

PI: Anthony McGoron
BIOMEDICAL ENGINEERING
Award Action Type: Initial
AWARDING SPONSOR: National Institutes of Health
TITLE: Novel Polymeric nanoparticles for drug delivery applications

AWARD: $

155,102

PI: Masoud Milani
COMPUTER INFO SCIENCES
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: RET in Engineering and Computer Site: Nanotechnology Research Experiences for Teachers at FIU
AWARD: $
PI: Masoud Milani
COMPUTER INFO SCIENCES
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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TITLE: Participant Payments: RET in Engineering and Computer Site: Nanotechnology Research Experiences for
Teachers at FIU
AWARD: $
384,000
PI: Osama A Mohammed
ELEC AND COMPUTER ENG
Award Action Type: Continuation
AWARDING SPONSOR: Office of Naval Research
TITLE: Real Time Modeling & Simulation Techniques using Intelligent Systems with a Reduced Scale Hardware
Demonstration of Smart Controls for Notional Ship Architecture
AWARD: $
110,000
PI: Giri Narasimhan
COMPUTER INFO SCIENCES
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: Graduate Research Fellowship Program

AWARD: $

2,000

PI: Olga Nazario
ARC APPLIED RESEARCH CENTER
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of State
TITLE: Energy and Climate Partnership of the Americas (ECPA) grant

AWARD: $

157,416

PI: Adly Norelus
STUDENT AFFAIRS VICE PRES OFF
Award Action Type: Initial
AWARDING SPONSOR: Florida Department of Agriculture and Co
TITLE: Summer Food Service Program

AWARD: $

11,187

PI: Laura A Ogden
SOUTHEAST ENV RESEARCH CTR
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: Graduate Research Fellowship Program

AWARD: $

2,000

AWARD: $

451,646

AWARD: $

36,891

AWARD: $

92,553

PI: Mark Benjamin Padilla
CENTER FOR CHILDREN AND FAM
Award Action Type: Initial
AWARDING SPONSOR: National Institute on Drug Abuse
TITLE: Migration, Tourism and the HIV-drug use Syndemic in the Dominican Republic
PI: Rene Price
SOUTHEAST ENV RESEARCH CTR
Award Action Type: Increase
AWARDING SPONSOR: South Florida Water Management District
TITLE: Hydrological Conditions of Mangrove Lakes Region of Everglades National Park
PI: Raphael G Raptis
CHEMISTRY
Award Action Type: Initial
AWARDING SPONSOR: American Chemical Society
TITLE: Synthesis and Characterization of Dyads Capable of Achieving
Photoexcited Two-Electron Charge-Separated States

For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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PI: Jennifer H Richards
BIOLOGY
Award Action Type: Increase
AWARDING SPONSOR: Fairchild Tropical Botanic Garden
TITLE: Fairchild Tropical Botanic Garden supports research and education in tropical botany. As a tangible expression of
this support, they provide graduate student support for individuals working for higher degrees in areas of tropical plant
science.
AWARD: $
213
PI: Naphtali Rishe
COMPUTER INFO SCIENCES
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: I/UCRC Phase II: Center for Advanced Knowledge Enablement

AWARD: $

81,750

PI: Camilo Rosales
ARCHITECTURE
Award Action Type: Initial
AWARDING SPONSOR: U.S. Department of State
TITLE: Energy and Climate Partnership of the Americas (ECPA) grant

AWARD: $

616,643

PI: Michael S Ross
SOUTHEAST ENV RESEARCH CTR
Award Action Type: Continuation
AWARDING SPONSOR: U.S. Army
TITLE: Landscaping Pattern: Marl Praire/Slough Gradients

AWARD: $

96,281

PI: Michael S Ross
SOUTHEAST ENV RESEARCH CTR
Award Action Type: Continuation
AWARDING SPONSOR: U.S. Army
TITLE: Monitoring of Tree Island Condition in South Everglades

AWARD: $

92,667

PI: Ernest Simms
STUDENT AFFAIRS VICE PRES OFF
Award Action Type: Continuation
AWARDING SPONSOR: U.S. Department of Education
TITLE: Educational Talent Search

AWARD: $

217,971

PI: Ernest Simms
STUDENT AFFAIRS VICE PRES OFF
Award Action Type: Continuation
AWARDING SPONSOR: U.S. Department of Education
TITLE: McNair 2012-2017

AWARD: $

218,915

PI: Ernest Simms
STUDENT AFFAIRS VICE PRES OFF
Award Action Type: Continuation
AWARDING SPONSOR: U.S. Department of Education
TITLE: Upward Bound Math-Science 12-17

AWARD: $

217,472

PI: Ernest Simms
STUDENT AFFAIRS VICE PRES OFF
Award Action Type: Continuation
AWARDING SPONSOR: U.S. Department of Education
TITLE: Subproject: Upward Bound Math-Science 12-17

AWARD: $

19,418

For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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PI: Mary Jo Trepka
EPIDEMIOLOGY
Award Action Type: Increase
AWARDING SPONSOR: Minority Health and Health Disparities
TITLE: Retrospective cohort study of racial disparities in HIV survival, Florida

November 2013

AWARD: $

100,000

PI: Yi Xiao
CHEMISTRY
Award Action Type: Initial
AWARDING SPONSOR: National Institute of Justice
TITLE: Aptamer-Based, Exonuclease-Amplified, Paper Device for Point of Collection Screening of Cocaine and
Methamphetamine in Oral Fluid
AWARD: $
352,223
PI: Changwon Yoo
BIOSTATISTICS
Award Action Type: Continuation
AWARDING SPONSOR: National Institutes of Health
TITLE: Identifying Key Genes that cause Aggressive Brain Cancer

AWARD: $

104,944

PI: Yimin Zhu
CONSTRUCTION MANAGEMENT
Award Action Type: Initial
AWARDING SPONSOR: National Science Foundation
TITLE: Collaborative Research: Cyber-Constructor: Enhancing spatial and temporal cognitive ability in construction
education through augmented reality
AWARD: $
50,793
PI: Yimin Zhu
CONSTRUCTION MANAGEMENT
Award Action Type: Initial
AWARDING SPONSOR: University of North Texas
TITLE: RCN-SEES: Predictive Modeling Network for Sustainable Human-Building Ecosystems (SHBE)
AWARD: $
31,500
PI: Yimin Zhu
CONSTRUCTION MANAGEMENT
Award Action Type: Initial
AWARDING SPONSOR: University of North Texas
TITLE: Participant Payments: RCN-SEES: Predictive Modeling Network for Sustainable Human-Building Ecosystems
(SHBE)
AWARD: $
31,000

Limited Submission Funding Opportunities
Below are limited submission funding opportunities with internal deadlines for the month of November 2013.
Agency:

Miami Dade County Department of Cultural Affairs

Program:

FY 2013-2014 TOURIST DEVELOPMENT COUNCIL GRANTS PROGRAM

Institutional Submission
Limits:

Two applications per fiscal year. *This is contingent upon the number of applications we
receive based on Miami-Dade County's fiscal year (October 1 - September 30)

Internal Proposal Deadline:
Agency Deadline:
Status:

11/15/2013
1/16/2014
Open

internal proposal application

For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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http://miamidadearts.culturegrants.org/navigation/links/page/tourist-development-counciltdc

Link:
Agency:

National Institutes of Health
Centers of Excellence for Research on CAM (P01) - AIDS Application
(PAR-12-151)

Program:
Institutional Submission
Limits:
Internal Proposal Deadline:
Agency Deadline:
Status:
Link:

November 2013

Only one application per institution is allowed.
11/25/2013
internal proposal application
AIDS Application: 01/07/2014
Open
http://grants.nih.gov/grants/guide/pa-files/PAR-12-151.html

Please visit our website at: http://research.fiu.edu/funding/pages/limited-submissions.html to review our monthly limited
submissions or for further instructions on how to prepare and/or submit your limited submission application.

Funding Opportunities
Department of Defense
Sea-Based Aviation National Naval Responsibility (SBA NNR) Structures and Materials Focus Area
Funding Opportunity Number: 13-SN-0025
Application Deadline: February 28, 2014
Description: This announcement describes the Sea-based Aviation National Naval Responsibility (SBA NNR) Structures
and Materials Focus Area research opportunity to be launched under the ONRBAA14-001, Long Range Broad Agency
Announcement for Navy and Marine Corps Science and Technology. The purpose of this announcement is to focus
attention of the scientific community on (1) the areas to be studied, and (2) the planned timetable for the initial round of
white paper submissions. http://www.grants.gov/searchgrants.html?agencies%3DDOD%7CDepartment%20of%20Defense
U.S. Army Medical Research and Materiel Command Broad Agency Announcement
Funding Opportunity Number: W81XWH-BAA-14-1
Application Deadline: September 30, 2014
Description: The U.S. Army Medical Research and Materiel Command's (USAMRMC) mission is to provide solutions to
medical problems of importance to the American Service member at home and abroad, as well as to the general public at
large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and
civilian medical science and technology, operational requirements, military threat assessments, and national defense
strategies. The extramural research and development program plays a vital role in the fulfillment of the objectives
established by the USAMRMC. General information on USAMRMC can be obtained at https://mrmc.detrick.army.mil/.
This BAA is intended to solicit extramural research and development ideas, and is issued under the provisions of the
Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation
6.102(d)(2) and 35.016. This BAA provides a general description of USAMRMC’s research and development programs,
including: research areas of interest; general information; evaluation and selection criteria; and proposal/application
preparation instructions. Research and development funded through this BAA is intended and expected to benefit and
inform both military and civilian medical practice and knowledge. In accordance with FAR 6.102, projects funded under
this BAA must be for basic and applied research and that part of development not related to the development of a specific
system or hardware procurement. Projects must be for scientific study and experimentation directed toward advancing the
state-of-the-art or increasing knowledge or understanding rather than focusing on a specific system or hardware solution.
This is a continuously open announcement; pre-proposal/pre-applications and full proposal/full applications may be
submitted at any time throughout the 12-month period. However, no proposal/application submitted under this BAA will
be considered for funding after 24 months from the date of submission. Before submitting full proposal/applications,
organizations are strongly encouraged to explore USAMRMC interest by submitting preliminary research
proposal/applications (pre-proposal/pre-applications). Pre-proposal/pre-applications may be submitted at any time prior to
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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the BAA closing date. This fiscal year’s BAA contains several changes from previous USAMRMC BAAs: research areas
of interest have been updated; instructions are provided for marking proprietary information if included in full
proposals/applications; information and instructions regarding Conflicts of Interest have been added; in addition to current
and pending support information, PIs and key personnel are required to provide prior (within the last 5 years) support
information; areas addressing Representations and Certifications have changed; attachment entitled “Organizational Data”
is added; attachment previously entitled “Certificate of Environmental Compliance” is changed to “Environmental
Compliance Assurance”; attachment entitled “Facility Safety Plan Instructions” has been updated.
http://www.grants.gov/search-grants.html?agencies%3DDOD%7CDepartment%20of%20Defense
Hypoxia Monitoring, Alert, and Mitigation System Funding Opportunity Number: 14-SN-0002
Application Deadline: November 22, 2013
Description: This announcement describes a research thrust entitled “Hypoxia Monitoring, Alert and Mitigation System”
(HAMS) to be launched under the ONR BAA 14-001, Long Range Broad Agency Announcement (BAA) for Navy and
Marine Corps Science and Technology which can be found at: http://www.onr.navy.mil/Contracts-Grants/FundingOpportunities/Broad-Agency-Announcements.aspx. The research opportunity described in this announcement specifically
falls under numbered paragraph 2 (item c) of the sub-section entitled Warfighter Performance (Warfighter Protection and
Applications). The submission of proposals, their evaluation and potential execution of funds will be carried out as
described in that BAA. The purpose of this announcement is to focus attention of the scientific community on the area to
be studied and the planned timetable for the submission of proposals. The FULL ANNOUNCEMENT is available on the
Grants.gov website by scrolling to the top of the synopsis page and clicking on the "FULL ANNOUNCEMENT" box
surrounded by the dotted line at the top of the page. http://www.grants.gov/searchgrants.html?agencies%3DDOD%7CDepartment%20of%20Defense
DoD Breast Cancer Postdoctoral Fellowship Award
Funding Opportunity Number: W81XWH-13-BCRP-POSTDOC2
Application Deadline: January 9, 2014
Description: The Postdoctoral Fellowship Award supports exceptionally talented recent doctoral or medical graduates in
pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the
necessary experience for an independent career at the forefront of breast cancer research. Those individuals should be
exceptionally talented scientists who have demonstrated that they are the “best and brightest” of their peers. Applicants
for this award must exhibit a strong desire to pursue a career in breast cancer research. Under this award mechanism, the
postdoctoral fellow is considered the Principal Investigator (PI) and, as such, should write the project narrative, training
plan, and other application components with appropriate guidance from the mentor. While the PI is not required to have
previous experience in breast cancer research, the proposed project and training must focus on breast cancer. Applications
must emphasize the PI’s high potential for success in becoming an independent breast cancer researcher based on his/her
qualifications, achievements (including first-author publications), and letters of recommendation. The mentor (or comentor, if applicable) must possess the appropriate expertise and experience in breast cancer, to include publications and
active peer reviewed breast cancer funding, and clearly demonstrate a commitment to guiding the PI’s research and
training. If the mentor is not an experienced breast cancer researcher, then formal co-mentorship by an established breast
cancer researcher is required. The application must include information about the mentor’s experience in conducting
innovative research and how he/she intends to support the PI’s endeavors in breast cancer. Mentorship by an investigator
without an established record of mentoring pre- and postdoctoral trainees may be offset by the overall strength of the
training plan. Applications must provide details on the suitability of the PI’s overall training plan and research project for
attaining the goals of this award mechanism. Applications must elaborate on the qualities of the training environment in
which the candidate will work, provide details on the individualized, breast cancer-focused training plan, and describe
how this training will facilitate the PI’s career development as an independent, innovative breast cancer researcher. A
multidisciplinary research approach to breast cancer is highly encouraged but not required; however, if there are
multidisciplinary aspects to the training, they should be clearly outlined in the application. The application must articulate
the potential impact that the proposed work will have on breast cancer. The research should be based on a sound scientific
rationale and/or a thorough review of the literature. Preliminary data are not required. http://www.grants.gov/searchgrants.html?agencies%3DDOD%7CDepartment%20of%20Defense
Systems-Based Neurotechnology for Emerging Therapies (SUBNETS)
Funding Opportunity Number: DARPA-BAA-14-09
Application Deadline: December 17, 2013
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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Description: DARPA seeks to develop a new understanding of complex, systems-based disorders of the brain. A major
goal of this effort is to deliver a platform technology for precise therapy in humans living with neuropsychiatric and
neurologic disease, including veterans and active duty soldiers suffering from mental health issues. Methods developed
through this program will use neural recording and stimulation to close the loop on therapeutic treatment in individuals
who receive minimal benefits from currently available treatments. This program could lead to improved knowledge of
multiple neural subnetworks of the brain that are involved in disease and illness. This program combines novel device
development, complex modeling of behaving human neural systems, clinical neurology, and animal research in order to
advance the understanding and translation of safe, effective neuro-technological therapies.
http://www.grants.gov/search-grants.html?agencies%3DDOD%7CDepartment%20of%20Defense
DoD Clinical and Rehabilitative Medicine Neurosensory Research Award
Funding Opportunity Number: W81XWH-13-DMRDP-CRMRP-NSRA
Application Deadline: February 11, 2014
Description: The FY13 DMRDP CRMRP Neurosensory Research Award (NSRA) is intended to support both applied
(preclinical) research and clinical trials within specific Focus Areas of pain management, hearing loss/dysfunction,
balance disorders, and/or tinnitus. Applications focused on traumatic brain injury (TBI) are highly encouraged.
http://www.grants.gov/search-grants.html?agencies%3DDOD%7CDepartment%20of%20Defense
DoD Clinical and Rehabilitative Medicine Neuro-musculoskeletal Injuries Research Award
Funding Opportunity Number: W81XWH-14-DMRDP-CRMRP-NMSIRA
Application Deadline: February 11, 2014
Description: The FY14 DMRDP CRMRP Neuro-musculoskeletal Injuries Research Award (NMSIRA) supports
preclinical research and clinical trials on the functional utility of assistive devices related to the human-device interface,
secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for
patients with severe extremity trauma. To meet the intent of the award mechanism, applications must specifically address
one or more of the FY14 DMRDP CRMRP NMSIRA Focus Areas listed below. Applications proposing research outside
of the Focus Areas listed below should not be submitted in response to this Program Announcement/Funding Opportunity.
 Improving the functional utility of assistive devices related to the human-device interface (prostheses, orthoses, and
other assistive devices)
 Improvements in prosthetic socket comfort, residual limb health, and function
 Providing proprioceptive and other sensory inputs to the user
 Improving user intent control of assistive devices
 Improving the ability to predict, identify and reduce secondary health effects that develop after severe primary neuromusculoskeletal injury
 Determining factors that predict development and successful treatment of osteoarthritis, low back pain, or other
musculoskeletal conditions
 Intervention strategies to diminish falls and decrease fracture risk
 Strategies to improve treatment and rehabilitation of heterotopic ossification
 Optimizing treatment strategies and sequence of progression throughout the rehabilitation process following severe
extremity trauma
 Determining the optimal combination, dose, and timing of rehabilitative techniques to minimize impairments and
maximize function and performance
 Objectively guiding prosthetic and/or orthotic prescription to minimize impairments and maximize function and
performance
If the proposed study involves the use of a drug or biologic that has not been approved by the Food and Drug
Administration (FDA) for its investigational use, evidence that an Investigational New Drug (IND) exemption application
has been submitted or will be submitted within 60 days of award is required. If the proposed study involves an
Investigational Device that has not been approved or cleared by FDA for its investigational clinical use, the study may be
required to comply with the FDA Investigational Device Exemption (IDE) regulations and evidence that an IDE has been
submitted or will be submitted within 60 days of the award date or that the device is exempt from an IDE is required. The
Government reserves the right to withdraw funding if the IND or IDE application has not been submitted to the FDA
within 60 days of the DoD award date or if the documented status of the IND or IDE has not been obtained within 6
months of the award date. http://www.grants.gov/searchgrants.html?agencies%3DDOD%7CDepartment%20of%20Defense
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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Environmental Protection Agency
Urban Waters Small Grants
Funding Opportunity Number: EPA-OW-IO-13-01
Application Deadline: Nov 25, 2013
Description: Under this announcement, the U.S. Environmental Protection Agency (EPA) is soliciting proposals from
eligible applicants for projects that will advance EPA’s water quality and environmental justice goals. Note that, for this
grant cycle, projects proposed for funding must take place entirely within and focus on one of 18 specific Eligible
Geographic Areas, as listed in Section I.A and illustrated on the Urban Waters Small Grants program mapping website
http://www2.epa.gov/urbanwaters/urban-waters-small-grants-mapping
http://www2.epa.gov/urbanwaters/urban-waters-small-grants
http://www2.epa.gov/sites/production/files/2013-09/documents/uwsg-rfp-09262013_0.pdf
FY 2014 National Environmental Information Exchange Network Grant Program
Funding Opportunity Number: EPA-OEI-14-01
Application Deadline: Nov 8, 2013
Description: The Exchange Network Grant Program provides funding to states, tribes, inter-tribal consortia and territories
to develop and implement the information technology and information management capabilities they need to actively
participate in the Exchange Network. This grant program supports the exchange of environmental data and collaborative
work within the Exchange Network. Grantees will share work products with all EN partners through EPA’s Reusable
Component Services (RCS) database. http://epa.gov/exchangenetwork/grants/
Gulf of Mexico Regional Partnerships – 2013
Funding Opportunity Number: EPA-GM-2013-1
Application Deadline: Nov 12, 2013
Description: The U.S. Environmental Protection Agency (EPA) – Gulf of Mexico Program (GMP) is soliciting initial
proposals under this announcement from eligible entities that address water quality monitoring and/or improvement,
coastal habitat and ecosystems enhancement and/or protection, community resilience, and environmental education and
outreach in the Gulf of Mexico region and its watersheds. The initial proposals will be short submissions describing a
project’s scope and environmental results, and will be evaluated to determine whether the applicant will be requested to
submit a full proposal. A broad range of entities, as described in Section III, are eligible to submit proposals under this
announcement for projects in the Gulf of Mexico region and its watersheds in the five states abutting the Gulf of Mexico
(Texas, Louisiana, Mississippi, Alabama, Florida), including their out-of-geographic-region contributory watersheds, that
address water quality monitoring and/or improvement, coastal habitat and ecosystems enhancement and/or protection,
community resilience and environmental education and outreach. http://epa.gov/gmpo/
Organotypic Culture Models for Predictive Toxicology Center
Funding Opportunity Number: EPA-G2013-STAR-L1
Application Deadline: Jan 23, 2014
Description: The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR)
program, is seeking applications for research centers to investigate toxic effects of chemical substances in threedimensional (3D) in vitro models, hereafter referred to as ‘organotypic culture models’ (OCMs). OCMs are tissue culture
models that mimic in vivo tissue architecture through interactions of heterotypic cell types (e.g., epithelium-stroma) and
extracellular matrices (ECM). They can be established from isolated cells or from tissue fragments harvested in vivo, and
will bridge the gap between conventional monolayer cell cultures and whole-animal systems. EPA is interested in the
potential application of OCMs that mimic complex cell arrangements and physiologies, scalable from mid to higher
throughput screening (HTS), and high-content screening (HCS) approaches. This solicitation seeks the formation of
research centers that will guide the development and evaluation of OCMs that will accelerate translational research in
predictive toxicology. http://www.epa.gov/ncer/rfa/2013/2013_star_ocm.html
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Florida Department of Health & Sanford-Burnham Medical Research Institute
Florida Translational Research Program
Funding Opportunity Number: N/A
Pre-Application Deadline: N/A
Application Deadline: Thursday, November 7, 2013, 5:00 p.m. EST
Description: The purpose of the Florida Translational Research Program (FTRP) is to produce a pipeline of potential new
medicines based upon laboratory research discoveries. The Program provides Florida-based scientists with access to
experienced professionals and state-of-the-art technological resources for drug discovery to facilitate an interdisciplinary,
collaborative approach to the establishment of a pipeline of potential new treatments for today’s most challenging and
unmet medical needs. The Program is funded by the state of Florida through the Florida Department of Health and is
administered and performed by Sanford-Burnham Medical Research Institute at Lake Nona. The goals of the FTRP are to
implement a variety of innovative biochemical and cell-based assays to interrogate biological targets or processes for
which there are limited selective and potent small-molecule modulators available; to execute high-throughput screens; and
to develop lead compounds suitable for use in vivo. To meet these objectives the Program seeks three types of early drug
discovery project proposals:
 Concept or assay development projects for use in pre-therapeutic discovery via high-throughput screening. This
solicitation invites proposals for the development of innovative biochemical and cell-based assays for biological
targets, pathways, or processes for which there are limited selective and potent small-molecule modulators available.
 High-throughput screening (HTS)-ready assays. This solicitation seeks well-developed, HTS-ready assays suitable for
high-throughput screening of the Sanford-Burnham library of compounds for the purpose of identifying smallmolecule modulators of the target, pathways, or processes of interest.
 Validated hits for the discovery of pre-therapeutic lead compounds. This solicitation invites proposals that aim to
further research and development of existing small-molecule chemical scaffolds for use in vivo.
http://www.sanfordburnham.org/technology/centers/cpccg/floridatranslationalresearchprogram/Pages/ProgramDescription.aspx

Institute of Museum and Library Services
Museums of America
Funding Opportunity Number: MFA-FY14
CFDA Number(s): 45.301
Deadline for Transmittal of Applications: December 2, 2013
Description: The Museums for America (MFA) program supports projects that strengthen the ability of an individual
museum to serve its public. MFA grants support activities that strengthen museums as active resources for lifelong
learning, as important institutions in the establishment of livable communities, and as good stewards of the nation’s
collections. MFA grants can fund both new and ongoing museum activities and programs. Examples include planning,
managing and conserving collections, improving public access, training, conducting programmatic research, school and
public programming, producing exhibitions, and integrating new or upgraded technologies into your operations. There are
three categories within the MFA program:
1. Learning Experiences IMLS
2. Community Anchors IMLS
3. Collections Stewardship
http://www.imls.gov/applicants/detail.aspx?GrantId=11 or www.grants.gov and search by opportunity number.
Sparks! Ignition Grants for Museums
Funding Opportunity Number: SPARKS-FY14
CFDA Number(s): 45.312
Deadline for Transmittal of Applications: December 2, 2013
Description: The Sparks! Ignition Grants for Museums program is a special funding opportunity within the IMLS
National Leadership Grants for Museums program, which supports projects that address problems, challenges, or needs of
broad relevance to museums. These small grants encourage museums to prototype and evaluate specific innovations in the
ways they operate and the services they provide resulting in new tools, products, services, or organizational practices.
http://www.imls.gov/applicants/detail.aspx?GrantId=23 or www.grants.gov and search by opportunity number.
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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National Leadership Grants for Museums
Funding Opportunity Number: NLG-MUSEUMS-FY14
CFDA Number(s): 45.312
Deadline for Transmittal of Applications: December 2, 2013
Description: National Leadership Grants (NLG) for Museums support projects that address current and future needs of
the museum field and that have the potential to advance practice in the profession so that museums can improve services
for the American public. Successful proposals will generate results such as models, new tools, research findings, services,
practices, and/or alliances that can be widely used, adapted, scaled, or replicated to extend and leverage the benefits of
federal investment. Applications should align with one of the following three funding categories:
1. Learning Experiences IMLS
2. Community Anchors IMLS
3. Collections Stewardship
http://www.imls.gov/applicants/detail.aspx?GrantId=22 or www.grants.gov and search by opportunity number.

Miami-Dade County Department of Cultural Affairs
Audience Access Grant Program
Funding Opportunity Number: N/A
Application Deadline: Ongoing
Description: The Department of Cultural Affairs is committed to continuing its collaborative efforts in working with
people with disabilities and cultural/community organizations to help address ADA compliance issues, programmatic
accessibility, and audience development and outreach efforts. The Department strives to ensure that all of its grantees are
likewise committed to making their facilities and programs accessible to people of all abilities. The Audience Access
Grant Program is designed to provide funding to promote and help pay for arts program ADA/access technology, such as
American Sign Language (ASL) interpreters, captioning, audio description, marketing materials, and other such services
to ensure programmatic access for audiences of all abilities. This program is not intended to provide assistance in funding
capital/facilities improvements, such as construction, renovation or major equipment purchases.
http://miamidadearts.culturegrants.org/navigation/links/page/audience-access-aud

National Aeronautics & Space Administration
Ocean Salinity Field Campaign
Funding Opportunity Number: NNH13ZDA001N-OSFC
Pre-Application Deadline: November 1, 2013
Application Deadline: December 2, 2013
Description: The objective of this program element is to select additional members to the NASA Ocean Salinity Science
Team for the analysis phase of a 2012-13 Ocean Salinity Field Campaign. This field campaign is known as the Salinity
Processes in the Upper-Ocean Regional Study (SPURS). The planned work coincides with the U.S.-Argentine
Aquarius/SAC-D and European SMOS surface salinity satellite missions, as well as the continuing, global array of ARGO
profiling floats, all of which provide excellent new tools to monitor ocean salinity. The SPURS field campaign is
underway (http://SPURS.jpl.nasa.gov) and this announcement anticipates the need for both analysis work and planning for
the next SPURS campaign (in a high precipitation, low salinity location circa 2015).
http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={1A42808C-0423-D8B5-34F9AAEE83031C2F}&path=open
Space Technology Research Fellowships
Funding Opportunity Number: NSTRF14
Application Deadline: November 13, 2013
Description: This call for graduate student fellowship applications, entitled NASA Space Technology Research
Fellowships (NSTRF) – Fall 2014 (NSTRF14), solicits applications from individuals pursuing or planning to pursue
master’s (e.g., M.S.) or doctoral (e.g., Ph.D.) degrees in relevant space technology disciplines at accredited U.S.
universities. NASA Space Technology Fellows will perform innovative space technology research and will improve
America’s technological competitiveness by providing the Nation with a pipeline of innovative space technologies.
http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId=%7bBD3F49F4-611F-D9EC-1B8416F4D7551609%7d&path=open
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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National Endowment for the Arts
NEA Our Town Application, FY 2014
Funding Opportunity Number: 2014NEA01OT
Application Deadline: January 13, 2014
Description: The Arts Endowment's support of a project may start on or after September 1, 2014. “Grant Program
Description” Art works to improve the lives of America’s citizens in many ways. Communities across our nation are
leveraging the arts and engaging design to make their communities more livable with enhanced quality of life, increased
creative activity, a distinct sense of place, and vibrant local economies that together capitalize on their existing assets. The
NEA defines these efforts as the process of Creative Place Making: "In creative place making, partners from public,
private, nonprofit, and community sectors strategically shape the physical and social character of a neighborhood, town,
tribe, city, or region around arts and cultural activities. Creative place making animates public and private spaces,
rejuvenates structures and streetscapes, improves local business viability and public safety, and brings diverse people
together to celebrate, inspire, and be inspired." Ann Markusen, Markusen Economic Research Services Anne Gadwa
Nicodemus, Metris Arts Consulting From Creative Place making Through Our Town, subject to the availability of
funding, the National Endowment for the Arts will provide a limited number of grants, ranging from $25,000 to $200,000,
for creative place making projects that contribute toward the livability of communities and help transform them into
lively, beautiful, and sustainable places with the arts at their core. http://www.grants.gov/web/grants/search-grants.html

National Endowment for the Humanities
Collaborative Research
Funding Opportunity Number: 20140107-RZ
Application Deadline: Jan 7, 2014
Description: Collaborative Research Grants support interpretive humanities research undertaken by a team of two or
more scholars, for full-time or part-time activities for periods of one to three years. Support is available for various
combinations of scholars, consultants, and research assistants; project-related travel; field work; applications of
information technology; and technical support and services. All grantees are expected to communicate the results of their
work to the appropriate scholarly and public audiences. Eligible projects include ¿ research that significantly adds to
knowledge and understanding of the humanities; ¿ conferences on topics of major importance in the humanities that will
benefit scholarly research; ¿ archaeological projects that include the interpretation and communication of results (projects
may encompass excavation, materials analysis, laboratory work, field reports, and preparation of interpretive
monographs); and ¿ research that uses the knowledge and perspectives of the humanities and historical or philosophical
methods to enhance understanding of science, technology, medicine, and the social sciences. Collaborative Research
Grants support interpretive humanities research undertaken by a team of two or more scholars, for full-time or part-time
activities for periods of one to three years. Support is available for various combinations of scholars, consultants, and
research assistants; project-related travel; field work; applications of information technology; and technical support and
services. All grantees are expected to communicate the results of their work to the appropriate scholarly and public
audiences. http://www.grants.gov/web/grants/search-grants.html
Scholarly Editions and Translations
Funding Opportunity Number: 20140107-RQ
Application Deadline: Jan 7, 2014
Description: Scholarly Editions and Translations grants support the preparation of editions and translations of preexisting texts and documents of value to the humanities that are currently inaccessible or available in inadequate editions.
These grants support full-time or part-time activities for periods of one to three years. Projects must be undertaken by a
team of at least one editor or translator and one other staff member. Grants typically support editions and translations of
significant literary, philosophical, and historical materials, but other types of work, such as musical notation, are also
eligible. Applicants should demonstrate familiarity with the best practices recommended by the Association for
Documentary Editing or the Modern Language Association Committee on Scholarly Editions. Translation projects should
also explain the approach adopted for the particular work to be translated. Editions and translations produced with NEH
support contain scholarly and critical apparatus appropriate to the subject matter and format of the edition. This usually
means introductions and annotations that provide essential information about the form, transmission, and historical and
intellectual context of the texts and documents involved. Proposals for editions of foreign language materials in the
original language are eligible for funding, as well as proposals for editions of translated materials.
http://www.grants.gov/web/grants/search-grants.html
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu
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National Digital Newspaper Program
Funding Opportunity Number: 20140115-PJ
Application Deadline: Jan 15, 2014
Description: NEH is soliciting proposals from institutions to participate in the National Digital Newspaper Program
(NDNP). NDNP is creating a national digital resource of historically significant newspapers published between 1836 and
1922, from all the states and U.S. territories. This searchable database will be permanently maintained at the Library of
Congress (LC) and will be freely accessible via the Internet. (See the website, Chronicling America: Historic American
Newspapers.) An accompanying national newspaper directory of bibliographic and holdings information on the website
directs users to newspaper titles available in all types of formats. During the course of its partnership with NEH, LC will
also digitize and contribute to the NDNP database a significant number of newspaper pages drawn from its own
collections. NEH intends to support projects in all states and U.S. territories, provided that sufficient funds allocated for
this purpose are available. One organization within each U.S. state or territory will receive an award to collaborate with
relevant state partners in this effort. Previously funded projects will be eligible to receive supplements for continued work,
but the program will give priority to new projects. In particular, the program will give priority to projects from states and
territories that have not received NDNP funding.
http://www.grants.gov/web/grants/search-grants.html

National Institutes of Health
Human Islet Research Network Coordinating Center (U01)
Funding Opportunity Number: RFA-DK-13-013
Application Receipt Date(s): February 27, 2014
Description: This Funding Opportunity Announcement will provide support for a Coordinating Center that will provide
the administrative infrastructure for the NIDDK funded Human Islet Research Network (HIRN).
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-013.html
Human Islet Research Network Bioinformatics Center (U01)
Funding Opportunity Number: RFA-DK-13-014
Application Receipt Date(s): February 27, 2014
Description: This Funding Opportunity Announcement (FOA) will provide support for a Bioinformatics Center that will
provide the expertise and infrastructure needed to enhance sharing and utility of data and resources to be produced by the
NIDDK-funded Human Islet Research Network. http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-014.html
Consortium on Targeting And Regeneration (CTAR) - HIRN (UC4)
Funding Opportunity Number: RFA-DK-13-015
Application Receipt Date(s): February 27, 2014
Description: This Funding Opportunity Announcement (FOA) requests applications for a new research consortium, the
Consortium on Targeting and Regeneration (CTAR), that will support the development of innovative strategies to increase
functional human beta cell mass in vivo through the controlled manipulation of beta cell replication or islet plasticity, or
the reprogramming of adult non-beta cells into beta-like cells. CTAR will be part of the Human Islet Research Network
(HIRN). http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-015.html
Consortium on Human Islet Biomimetics (CHIB) - HIRN (UC4)
Funding Opportunity Number: RFA-DK-13-016
Application Receipt Date(s): February 27, 2014
Description: This FOA invites new applications to participate in the Consortium on Human Islet Biomimetics (CHIB)
that will support the development of a human islet microphysiological system or niche (a system that combines cells,
cytoarchitecture, matrix, physical factors, secreted factors, etc.). CHIB will be part of the Human Islet Research Network
(HIRN). http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-016.html
Consortium on Modeling Autoimmune Interactions (CMAI) - HIRN (UC4)
Funding Opportunity Number: RFA-DK-13-017
Application Receipt Date(s): February 27, 2014
Description: This Funding Opportunity Announcement (FOA) invites new applications to participate in a Consortium on
Modeling Autoimmune Interactions (CMAI) that will be focused on the goal of developing robust systems to measure and
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model the biology of human type 1 diabetes. CMAI will be a founding consortium within the Human Islet Research
Network (HIRN). Please limit this field to a brief description of ¼ to ½ page in length. Brevity is appreciated.
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-017.html
Consortium on Beta-cell Death and Survival (CBDS) - HIRN (UC4)
Funding Opportunity Number: RFA-DK-13-018
Application Receipt Date(s): February 27, 2014
Description: This Funding Opportunity Announcement (FOA) requests applications for a new research consortium, the
Consortium on Beta cell Death and Survival (CBDS). The mission of CBDS will be to better define and detect the
mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of
protecting the residual beta cell mass in T1D patients as early as possible in the disease process. CBDS will be part of the
Human Islet Research Network (HIRN). http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-018.html
Cigarette Tobacco Reference Products Program (UC2)
Funding Opportunity Number: RFA-FD-14-001
Application Receipt Date(s): November 15, 2013
Description: FDA's CTP is seeking to develop a cigarette tobacco reference products program that will require significant
collaboration and research efforts with outside organizations. The selected organization(s) will develop tobacco reference
products representing American blended cigarettes to be used for investigational non-clinical purposes by tobacco
manufacturers, contract and government laboratories, and academic institutions. http://grants.nih.gov/grants/guide/rfafiles/RFA-FD-14-001.html
Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science (U54)
Funding Opportunity Number: RFA-OD-13-117
Application Receipt Date(s): December 10, 2013
Description: This Funding Opportunity Announcement (FOA) invites applications for a Center for Evaluation and
Coordination of Training and Research (CECTR) in Tobacco Regulatory Science. The CECTR will become a national
resource in tobacco regulatory science, will support and conduct an evaluation of the scientific programs funded by the
Food and Drug Administration (FDA) Center for Tobacco Products (CTP), and will facilitate coordination and
communications of research and scientific training within those programs. The overall objective of the CECTR is to
evaluate and support training and research programs that can inform the FDA CTP in the development and evaluation of
tobacco product regulatory activities and actions. Through leadership, evaluation, coordination, and facilitation of
collaborative efforts, the CECTR can accelerate the advancement of science relevant to the Family Smoking Prevention
and Tobacco Control Act (FSPTCA). The NIH and the FDA have formed an interagency partnership to foster research
relevant to FDA's tobacco regulatory authorities. The award under this FOA will be administered by NIH using
designated funds from the FDA CTP for tobacco regulatory science mandated by the Family Smoking Prevention and
Tobacco Control Act (FSPTCA), Public Law 111-31. http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-13-117.html
Nutrition and Alcohol-Related Health Outcomes (R01)
Funding Opportunity Number: PA-13-359
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This Funding Opportunity Announcement (FOA) encourages applications that propose to examine
associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this FOA is
to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of
alcohol-related health outcomes including alcohol use disorder and chronic disease. http://grants.nih.gov/grants/guide/pafiles/PA-13-359.html
Nutrition and Alcohol-Related Health Outcomes (R03)
Funding Opportunity Number: PA-13-360
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This Funding Opportunity Announcement (FOA) encourages applications that propose to examine
associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this
FOA is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a
variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.
http://grants.nih.gov/grants/guide/pa-files/PA-13-360.html
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Nutrition and Alcohol-Related Health Outcomes (R21)
Funding Opportunity Number: PA-13-361
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This Funding Opportunity Announcement (FOA) encourages applications that propose to examine
associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this FOA is
to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of
alcohol-related health outcomes including alcohol use disorder and chronic disease.
http://grants.nih.gov/grants/guide/pa-files/PA-13-361.html
Research on the Health Determinants and Consequences of Violence and its Prevention, Particularly Firearm
Violence (R01)
Funding Opportunity Number: PA-13-363
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and
Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational
studies, intervention development at the individual, family and community level, efficacy trials of interventions based on
evidence from basic and translational studies, and research to identify the best ways to disseminate and implement
efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned
above, particular consideration will be given to applications that propose studies of the intersection that focus on the
various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.
http://grants.nih.gov/grants/guide/pa-files/PA-13-363.html
Research on the Health Determinants and Consequences of Violence and its Prevention, Particularly Firearm
Violence (R03)
Funding Opportunity Number: PA-13-368
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and
Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational
studies, intervention development at the individual, family and community level, efficacy trials of interventions based on
evidence from basic and translational studies, and research to identify the best ways to disseminate and implement
efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned
above, particular consideration will be given to applications that propose studies of the intersection that focus on the
various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.
http://grants.nih.gov/grants/guide/pa-files/PA-13-368.html
Research on the Health Determinants and Consequences of Violence and its Prevention, Particularly Firearm
Violence (R21)
Funding Opportunity Number: PA-13-369
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and
Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational
studies, intervention development at the individual, family and community level, efficacy trials of interventions based on
evidence from basic and translational studies, and research to identify the best ways to disseminate and implement
efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned
above, particular consideration will be given to applications that propose studies of the intersection that focus on the
various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.
http://grants.nih.gov/grants/guide/pa-files/PA-13-369.html
Neurological Sciences Academic Development Award (K12)
Funding Opportunity Number: PAR-13-362
Application Receipt/Submission Date(s): December 11, 2013, October 12, 2014, October 12, 2015
Description: The purpose of the NINDS Neurological Sciences Academic Development Award (NSADA K12) is to
facilitate and support the research career development of pediatric neurologists at educational institutions or professional
organizations who have made a commitment to independent research careers. The NSADA program is intended to
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provide three consecutive years of support to individuals to provide them with the knowledge, tools and research
experience that will enable them to transition to significant, individually-supported research.
http://grants.nih.gov/grants/guide/pa-files/PAR-13-362.html
Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01)
Funding Opportunity Number: PAR-13-364
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: The participating NIH Institutes and Centers invite Research Project Grant (R01) applications to develop
assays for high throughput screening (HTS) for use in Probe and Pre-therapeutic Discovery. Through this FOA, NIH
wishes to stimulate research in 1) developing assays for specific biological targets and disease mechanisms relevant to the
mission of participating NIH Institutes with the intent to screen for small molecule compounds that show potential as
probes for use in advancing knowledge about the known targets, identifying new targets, or as pre-therapeutic leads; and
2) establishing collaboration with screening centers that have the requisite expertise and experience needed in
implementation of HTS assays for the discovery and development of small molecule chemical probes. This FOA seeks to
establish a stream of scientifically and technologically outstanding assays for screening by the NIH Molecular Libraries
Production Centers Network (MLPCN) in the Molecular Libraries Program (MLP) and other academic centers. One
important criterion for this initiative is novelty, so applicants are therefore encouraged to avoid focusing on areas and
approaches that have been extensively targeted in other settings. Assays should be relevant to the scope of research in at
least one of the participating NIH Institutes. http://grants.nih.gov/grants/guide/pa-files/PAR-13-364.html
Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)
Funding Opportunity Number: PAR-13-365
Application Receipt/Submission Date(s): March 3, 2014, July 1, 2014, November 3, 2014, March 2, 2015 , July 1, 2015,
November 2, 2015, March 1, 2016, July 1, 2016, and November 1, 2016
Description: The purpose of this Research Demonstration and Disseminations Projects (R18) Funding Opportunity
Announcement (FOA) is to support research to evaluate large scale policies or programs related to healthcare delivery that
are expected to influence diabetes prevention and care. This FOA is not intended to support the initiation and delivery of
new policies or programs. Research support is for the evaluation of the effectiveness of healthcare programs and/or
policies implemented independent of NIH grant funding. The goal is to support research that meaningfully informs
clinical practice and health policy related to prevention or management of diabetes.
http://grants.nih.gov/grants/guide/pa-files/PAR-13-365.html
Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18)
Funding Opportunity Number: PAR-13-366
Application Receipt/Submission Date(s): March 3, 2014, July 1, 2014, November 3, 2014, March 2, 2015 , July 1, 2015,
November 2, 2015, March 1, 2016, July 1, 2016, and November 1, 2016
Description: The purpose of this Research Demonstration and Dissemination Projects (R18) Funding Opportunity
Announcement (FOA) is to support research to test approaches to improve diabetes treatment and prevention in existing
healthcare settings. Applications are sought that test practical and potentially sustainable strategies, delivered in routine
clinical care settings, to improve processes of care and health outcomes of individuals who are at risk for or have diabetes.
The goal is that the research results will improve routine clinical practice and inform policy in representative healthcare
settings. http://grants.nih.gov/grants/guide/pa-files/PAR-13-366.html
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34)
Funding Opportunity Number: PAR-13-367
Application Receipt/Submission Date(s): March 3, 2014, July 1, 2014, November 3, 2014, March 2, 2015 , July 1, 2015,
November 2, 2015, March 1, 2016, July 1, 2016, and November 1, 2016
Description: The purpose of this Planning Grant (R34) is to support research to develop and pilot test approaches to
improve diabetes treatment and prevention in existing healthcare settings. Applications should pilot test practical and
potentially sustainable strategies, delivered in routine clinical care settings, to improve processes of care and health
outcomes of individuals who are at risk for or have diabetes. The goal is that, if the pilot study shows promise, the data
from the R34 will be used to support a full scale trial that could improve routine clinical practice and inform policy in
representative healthcare settings. http://grants.nih.gov/grants/guide/pa-files/PAR-13-367.html
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Research Answers to NCIs Provocative Questions - Group A (R01)
Funding Opportunity Number: RFA-CA-13-016
Application Receipt Date(s): January 15, 2014, and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Initiative involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01
FOAs and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering
of questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This
FOA using the R01 funding mechanism solicits applications for PQs in Group A. The companion FOA for PQs in Group
A, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-017. PQs in this group challenge
investigators to seek answers to specific unsolved problems generally related to investigation of changes in behavior and
various exposure risks, mechanistic links between cancer risk factors and biological events associated with cancer
development, and how we might identify and better understand prevention mechanisms. Each research project proposed
in response to this FOA must be focused on addressing one particular research problem defined by one specific PQ
selected from the list in Group A. Projects proposed to address specific PQs may use strategies that incorporate ideas
and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve
the scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis;
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-016.html
Research Answers to NCI's Provocative Questions - Group A (R21)
Funding Opportunity Number: RFA-CA-13-017
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Program involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
(RFA-CA-13-017), using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group
A. The companion FOA for PQs in Group A, using the R01 funding mechanism, is RFA-CA-13-016. PQs in this group
challenge investigators to seek answers to specific unsolved problems generally related to investigation of changes in
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behavior and various exposure risks, mechanistic links between cancer risk factors and biological events associated with
cancer development, and how we might identify and better understand prevention mechanisms. Each research project
proposed in response to this FOA must be focused on addressing one particular research problem defined by one specific
PQ selected from the list in Group A. Projects proposed to address specific PQs may use strategies that incorporate ideas
and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve
the scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis;
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-017.html
Research Answers to NCIs Provocative Questions - Group B (R01)
Funding Opportunity Number: RFA-CA-13-018
Application Receipt Date(s): January 15, 2014, and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Initiative involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
(RFA-CA-13-018), using the R01 funding mechanism, solicits applications for PQs in Group B. The companion FOA for
PQs in Group B, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-019. PQs in this group
challenge investigators to seek answers to specific unsolved problems generally related to mechanisms of tumor
development or recurrence. Each research project proposed in response to this FOA must be focused on solving one
particular research problem defined by one specific PQ selected from the list in Group B. Projects proposed to address
specific PQs may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate.
Transdisciplinary projects are encouraged as long as they serve the scientific focus of the specific PQ chosen. The other
four groups of PQs (and their respective FOAs) are:
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis;
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-018.html
Research Answers to NCIs Provocative Questions - Group B (R21)
Funding Opportunity Number: RFA-CA-13-019
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
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initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing, respectively, the R01 and R21
funding mechanisms. The current reissuance of the PQ Program involves an updated set of 20 PQs. In order to facilitate
the peer review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01
FOAs and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering
of questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This
FOA, using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group B. The
companion FOA for PQs in Group B, using the R01 funding mechanism, is RFA-CA-13-018. PQs in this group challenge
investigators to seek answers to specific unsolved problems generally related to mechanisms of tumor development or
recurrence. Each research project proposed in response to this FOA must be focused on solving one particular research
problem defined by one specific PQ selected from the list in Group B. Projects proposed to address specific PQs may use
strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are
encouraged as long as they serve the scientific focus of the specific PQ chosen. The other four groups of PQs (and their
respective FOAs) are:
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis;
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-019.html
Research Answers to NCIs Provocative Questions - Group C (R01)
Funding Opportunity Number: RFA-CA-13-020
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Initiative involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
(RFA-CA-13-020), using the R01 funding mechanism, solicits applications for PQs in Group C. The companion FOA for
PQs in Group C, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-021. PQs in this group
challenge investigators to seek answers to specific unsolved problems generally related to the development or refinement
of methods to detect or diagnose tumors and highlight our still nascent knowledge of the stages of tumor development as
they relate to determining which tumors are most likely to lead to more aggressive states. Each research project proposed
in response to this FOA must be focused on solving one particular research problem defined by one specific PQ selected
from the list in Group C. Projects proposed to address specific PQs may use strategies that incorporate ideas and
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
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Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-020.html
Research Answers to NCIs Provocative Questions - Group C (R21)
Funding Opportunity Number: RFA-CA-13-021
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Program involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
(RFA-CA-13-021), using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group
C. The companion FOA for PQs in Group C, using the R01 funding mechanism, is RFA-CA-13-020. PQs in this group
challenge investigators to seek answers to specific unsolved problems generally related to the development or refinement
of methods to detect or diagnose tumors and highlight our still nascent knowledge of the stages of tumor development as
they relate to determining which tumors are most likely to lead to more aggressive states. Each research project proposed
in response to this FOA must be focused on solving one particular research problem defined by one specific PQ selected
from the list in Group C. Projects proposed to address specific PQs may use strategies that incorporate ideas and
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-021.html
Research Answers to NCIs Provocative Questions - Group D (R01)
Funding Opportunity Number: RFA-CA-13-022
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
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gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Initiative involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
(RFA-CA-13-022), using the R01 funding mechanism, solicits applications for PQs in Group D. The companion FOA for
PQs in Group D, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-023. PQs in this group
challenge investigators to seek answers to specific unsolved problems generally related to the development and use of new
therapeutic agents and how we can learn from both the successes and failures of clinical treatment. Each research project
proposed in response to this FOA must be focused on solving one particular research problem defined by one specific PQ
selected from the list in Group D. Projects proposed to address specific PQs may use strategies that incorporate ideas and
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-022.html
Research Answers to NCIs Provocative Questions - Group D (R21)
Funding Opportunity Number: RFA-CA-13-023
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Program involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
(RFA-CA-13-023), using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group
D. The companion FOA for PQs in Group D, using the R01 funding mechanism, is RFA-CA-13-022. PQs in this group
challenge investigators to seek answers to specific unsolved problems generally related to the development and use of new
therapeutic agents and how we can learn from both the successes and failures of clinical treatment. Each research project
proposed in response to this FOA must be focused on solving one particular research problem defined by one specific PQ
selected from the list in Group D. Projects proposed to address specific PQs may use strategies that incorporate ideas and
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
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Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis; and
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical
effectiveness.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-023.html
Research Answers to NCIs Provocative Questions - Group E (R01)
Funding Opportunity Number: RFA-CA-13-024
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Initiative involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
(RFA-CA-13-024), using the R01 funding mechanism, solicits applications for PQs in Group E. The companion FOA for
PQs in Group E, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-025. PQs in this group
challenge investigators to seek answers to specific unsolved problems generally related to the development of methods to
optimize the application of cancer treatments or interventions for enhanced clinical effectiveness. Each research project
proposed in response to this FOA must be focused on solving one particular research problem defined by one specific PQ
selected from the list in Group E. Projects proposed to address specific PQs may use strategies that incorporate ideas and
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis; and
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-024.html
Research Answers to NCIs Provocative Questions - Group E (R21)
Funding Opportunity Number: RFA-CA-13-025
Application Receipt Date(s): January 15, 2014 and June 20, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding
mechanisms. The current reissuance of the PQ Program involves an updated set of 20 PQs. In order to facilitate the peer
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs
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and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA
using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group E. The companion
FOA for PQs in Group E, using the R01 funding mechanism, is RFA-CA-13-024. PQs in this group challenge
investigators to seek answers to specific unsolved problems generally related to the development of methods to optimize
the application of cancer treatments or interventions for enhanced clinical effectiveness. Each research project proposed in
response to this FOA must be focused on solving one particular research problem defined by one specific PQ selected
from the list in Group E. Projects proposed to address specific PQs may use strategies that incorporate ideas and
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention
and risk;
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of
tumor development or recurrence;
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection,
diagnosis, and prognosis; and
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-025.html
Interpreting Variation in Human Non-Coding Genomic Regions Using Computational Approaches and
Experimental Assessment (R01)
Funding Opportunity Number: RFA-HG-13-013
Application Receipt Date(s): January 21, 2014 and January 21, 2015
Description: This Funding Opportunity Announcement (FOA) solicits applications to develop highly innovative
computational approaches for interpreting sequence variants in the non-protein-coding regions of the human genome. The
goal is to develop methods that analyze whole-genome sequence data by integrating data sets, such as ones on genome
function, phenotypes, patterns of variation, and other features, to identify or substantially narrow the set of variants that
are candidates for affecting organismal function leading to disease risk or other traits. The accuracy of the computational
approaches developed should be assessed using experimental data. http://grants.nih.gov/grants/guide/rfa-files/RFA-HG13-013.html
Patient-Centered Outcomes Research (PCOR) for Treatment Options in Uterine Fibroids: Developing a
Prospective Multi-Center Practice-based Clinical Registry (P50)
Funding Opportunity Number: RFA-HS-14-006
Application Receipt Date(s): December 16, 2013
Description: The Agency for Healthcare Research and Quality (AHRQ), in partnership with the Patient-Centered
Outcomes Research Institute (PCORI), invites applications for funding to examine the relative effectiveness of treatment
options for women of childbearing age with uterine fibroids. For women with symptomatic uterine fibroids, it is unclear
which treatment strategies are more effective in managing symptoms and addressing patient preferences for reproductive
options. As a result, patients and their clinicians often must decide on a plan of action without guidance from strong
scientific evidence. Due to the complexity of treatment options, high quality evidence can help women select specific
treatment options tailored to their individual preferences. AHRQ and PCORI intend to fund one application that will
include a registry Research and Data Coordinating Center (RDCC) to build a registry infrastructure that involves six to ten
separate and geographically diverse clinical centers (CC). http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-14006.html
NEI Translational Research Program (TRP) on therapy for Visual Disorders (R24)
Funding Opportunity Number: PAR-13-370
Application Receipt Date(s): January 28, 2014, January 28, 2015, and January 28, 2016
Description: The National Eye Institute (NEI) announces the reissue of PAR-10-281, "Translational Research Program
(TRP) on Therapy for Visual Disorders". This program focuses on the development of novel therapies to treat visual
diseases and disorders. In the context of this program, an expert develops a multi-disciplinary research team that applies
an integrative approach to develop rapid and efficient translation of innovative laboratory research findings into clinical
therapeutic development. It involves collaborative teams of scientists and clinicians with expertise in multiple disciplines,
operating according to a clear leadership plan. Such a collaborative approach is particularly appropriate for research
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focused on pathways that will likely be targeted by biological intervention, such as gene therapy, cell-based therapy, and
pharmacological approaches. The intention of this program is to make resources available to scientists from several
disciplines to address scientific and technical questions that would be beyond the capabilities of any one research
group. Each project should have a well-defined end-point, achievable within a five-year time frame, of developing a
specific treatment for a specific ocular disease. The steps towards this goal should be clearly delineated in a series of
milestones that support the development of a therapeutic, which can then be tested in a clinical trial. Highest
programmatic priority will be given to applications aligned with NEI's audacious goal initiative
(http://nei.nih.gov/audacious/). If successful, a project funded under this program could lead to filing an IND and a
subsequent application for an NEI U10 Clinical Vision Research Grant or an R34 Clinical Study Development Grant.
http://grants.nih.gov/grants/guide/pa-files/PAR-13-370.html
Planning for a National Center for Particle Beam Radiation Therapy Research (P20)
Funding Opportunity Number: (PAR-13-371)
Application Receipt/Submission Date(s): January 21, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage and support planning
efforts for establishing a Center for Particle Beam Radiation Therapy (PBRT) Research. The Center must be planned to
operate as a research center adjunct to an independently created and funded, sustainable clinical facility for PBRT.
Ultimately, the proposed Center is expected to perform clinically relevant research using proton and heavier ion beams
(including but not necessarily limited to carbon beams). The goal of this FOA is to provide the awardees with funding to
enable inclusion of necessary resources (expertise or facilities) to carry out basic, and translational, and clinical research
complementary to a clinical PBRT facility. The necessary expertise and efforts would be provided by a multidisciplinary
team of basic, translational, and clinical researchers, including physicists, engineers, biologists, and physicians, while the
research facilities may include, by way of example, cell culture laboratories, vivarium, and clinical anesthesia units for
pediatric patients. Applicants responding to this FOA must propose at least one pilot project that will enable a PBRT
research agenda in particle beam delivery systems, dosimetry, radiation biology, or translational pre-clinical studies. It is
expected that this effort will lead to a national research resource capable of successfully competing for and securing the
funding required to operate a specialized research center for clinical PBRT. This FOA is designed to support solely the
planning for a Research Center at a separately funded PBRT facility, and not the PBRT facility itself.
http://grants.nih.gov/grants/guide/pa-files/PAR-13-371.html
Modeling Social Behavior (R01)
Funding Opportunity Number: (PAR-13-374)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This Funding Opportunity Announcement (FOA) encourages applications for developing and testing
innovative theories and computational, mathematical, or engineering approaches to deepen our understanding of complex
social behavior. This research will examine phenomena at multiple scales to address the emergence of collective
behaviors that arise from individual elements or parts of a system working together. Emergence can also describe the
functioning of a system within the context of its environment. Often properties we associate with a system itself are in
actuality properties of the relationships and interactions between a system and its environment. This FOA will support
research that explores the often complex and dynamic relationships among the parts of a system and between the system
and its environment in order to understand the system as a whole. To accomplish the goals of this initiative, we encourage
applications that build transdisciplinary teams of scientists spanning a broad range of expertise. Minimally this team
should include investigators with expertise in the behavioral or social sciences as well as in computational and systems
modeling (computer science, mathematics, engineering, or other systems sciences). Applications should demonstrate
bridge-building between disciplines, scales and levels. http://grants.nih.gov/grants/guide/pa-files/PAR-13-374.html
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)
Funding Opportunity Number: (PAR-13-375)
Application Receipt/Submission Date(s): March 20, 2014; March 19, 2015; March 22, 2016
Description: The main objective of this Funding Opportunity Announcement (FOA) is to promote application of
nutrigenetics and/or nutrigenomics approaches to nutrition research through collaborative interaction among nutrition
researchers and experts in omics technologies. http://grants.nih.gov/grants/guide/pa-files/PAR-13-375.html
NIBIB Biomedical Technology Resource Centers (P41)
Funding Opportunity Number: (PAR-13-376)
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Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology
Resource Centers (BTRCs) that are funded using the P41 mechanism. BTRCs conduct research and development on new
technologies that are driven by the needs of basic, translational, and clinical researchers. BTRCs also make their
technologies available, train members of the research community in the use of the technologies, and disseminate these
technologies broadly. http://grants.nih.gov/grants/guide/pa-files/PAR-13-376.html
Secondary Analyses of Social and Behavioral Datasets in Aging (R03)
Funding Opportunity Number: (RFA-AG-14-008)
Application Receipt Date(s): February 03, 2014
Description: The purpose of this FOA is to solicit R03 applications for up to two years for secondary analysis of data on
aging in the areas of psychology, social epidemiology, economics, sociology, and demography.
http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-14-008.html
Pilot Clinical Trials to Eliminate the Latent HIV Reservoir (U01)
Funding Opportunity Number: (RFA-AI-13-055)
Application Receipt Date(s): March 07, 2014
Description: This Funding Opportunity Announcement (FOA) solicits applications for support of pilot clinical trials to
evaluate interventions aimed at the elimination of the HIV reservoir in HIV-infected adults who are on suppressive
antiretroviral therapy. It is expected that the trials will be fully integrated with laboratory-based analytical tools to detect
and measure elimination of latently-infected cells both in blood and in tissue.
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-13-055.html
Sub-Saharan African Collaborative HIV and Cancer Consortia (U54)
Funding Opportunity Number: (RFA-CA-13-010)
Application Receipt Date(s): January 17, 2014
Description: The purpose of this Funding Opportunity Announcement (FOA) is to promote and facilitate research on
HIV and cancer in Africa through collaborative efforts between investigators in United States (U.S.) and investigators in
sub-Saharan African countries. The FOA solicits applications for Specialized Center Cooperative Agreements (U54) for
research on HIV-associated cancers from research institutions in the U.S. and sub-Saharan Africa. Each application is
required to propose between two to four research projects that address high-priority questions relevant to the African
country. The proposed projects may range, as appropriate, from basic research to translational efforts as well as
population and implementation studies. Clinical trials, however, will not be supported. In addition, the proposed
Consortium must include two mandatory cores; an Administrative/Coordinating Core and a Mentoring/Career
Development Core. Additional cores such as any technical shared resources cores may be included as appropriate for the
needs of the projects.
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-010.html
Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological
Diseases (U01)
Funding Opportunity Number: (RFA-DK-13-026)
Application Receipt Date(s): March 19, 2014
Description: The purpose of this FOA is to establish a consortium to carry out research on novel methods for detection
and measurement of organ fibrosis after acute or chronic injury in kidney, bone marrow, prostate, or urinary tract.
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-026.html
Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB)
Diseases in Adults and Children (R01)
Funding Opportunity Number: (RFA-HL-14-023)
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015
Description: This Funding Opportunity Announcement (FOA) invites clinical research project grant (R01) applications
on the prevention, diagnosis, and treatment of HIV-related heart, lung, and/or blood (HLB) diseases in adults and
children. Proposed projects may utilize various approaches such as observational studies; quasi-experimental designs; and
single-center, pilot trials. Whenever possible, investigators are strongly encouraged to leverage existing infrastructure
such as clinical cohorts, biological specimens and imaging banks. The goal of this FOA is to address major scientific gaps
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in characterizing, preventing, diagnosing, or treating HIV-related HLB diseases and foster multi-disciplinary
collaborations among investigators.
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-023.html
Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children
(R01)
Funding Opportunity Number: (RFA-HL-14-024)
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015
Description: This Funding Opportunity Announcement (FOA) invites basic research project grant (R01) applications to
investigate the fundamental mechanisms underlying the pathogenesis of HIV-related heart, lung, and/or blood (HLB)
diseases alone and in the context of antiretroviral therapy (ART). Investigations may be conducted on various primary cell
types, biospecimens, computational models, and animal models, particularly those used for HIV research. The goal is to
provide the critical basic science foundation and guide the design of new therapeutic approaches for HIV-related HLB
conditions in adults and children.
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-024.html
Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children
(R21)
Funding Opportunity Number: (RFA-HL-14-029)
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015
Description: This Funding Opportunity Announcement (FOA) invites basic research project grant (R21) applications to
investigate the fundamental mechanisms underlying the pathogenesis of HIV-related heart, lung, and/or blood (HLB)
diseases alone and in the context of antiretroviral therapy (ART). Investigations may be conducted on various primary cell
types, biospecimens, computational models, and animal models, particularly those used for HIV research. The goal is to
provide the critical basic science foundation and guide the design of new therapeutic approaches for HIV-related HLB
conditions in adults and children.
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-029.html
Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN)
(U01)
Funding Opportunity Number: (RFA-TR-13-003)
Application Receipt Date(s): December 19, 2013
Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite new and renewal cooperative
agreement applications for the DMCC, which supports the RDCRN. The Network facilitates clinical research in rare
diseases through support for 1) collaborative clinical research in rare diseases, including longitudinal studies of
individuals with rare diseases, clinical studies and/or phase I , II and II/III trials; 2) training of clinical investigators in
rare diseases research; 3) pilot and demonstration projects; 4) clinical data management that incorporates novel
approaches and technologies for data management, data mining, and data sharing across rare diseases, data types, and
platforms; and 5) access to information related to rare diseases for basic and clinical researchers, academic and practicing
physicians, patients, and the lay public. The DMCC (U01) cooperative agreement application will focus on innovative
ways to provide the infrastructure and support to the individual sites in their activities relevant to items 1-3 as well as a
focus on issues relevant to items 4 and 5. See companion FOA RFA-TR-13-002
http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-13-003.html
Research on Malignancies in the Context of HIV/AIDS (R01)
Funding Opportunity Number: (PA-13-377)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This funding opportunity announcement (FOA) encourages Research Project Grant (R01) applications from
institutions/ organizations that propose to continue advancing our understanding of the risks, development, progression,
diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV)
infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR encourage research in areas such as
the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS
defining and AIDS-defining malignancies in diverse populations. This FOA encourages research efforts that will (i)
provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific
contributions resulting from HIV infection and its potential interaction with other pathogens for the development and
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu

Page 34

DoR Communicator

November 2013

pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the
HIV-infected population.
http://grants.nih.gov/grants/guide/pa-files/PA-13-377.html
Research on Malignancies in the Context of HIV/AIDS (R21)
Funding Opportunity Number: (PA-13-378)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: This funding opportunity announcement (FOA) encourages Research Project Grant (R21) applications from
institutions/organizations that propose to continue advancing our understanding of the risks, development, progression,
diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV)
infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR encourage research in areas such as
the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS
defining and AIDS-defining malignancies in diverse populations. This FOA encourages research efforts that will (i)
provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific
contributions resulting from HIV infection and its potential interaction with other pathogens for the development and
pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the
HIV-infected population.
http://grants.nih.gov/grants/guide/pa-files/PA-13-378.html
Administrative Supplements to NIH Awards for Validation Studies of Analytical Methods for Natural Products
(Admin Supp)
Funding Opportunity Number: (PA-13-381)
Application Receipt/Submission Date(s): January 31, 2014; June 30, 2014, October 31, 2014; January 31 2015; June 30
2015; October 31, 2015
Description: This Funding Opportunity Announcement (FOA) announces an administrative supplement program to
provide funds to NCI- and NIDDK-supported research projects for validation studies of new analytical chemistry
methods. These methods must have been developed or be under development by the awardees during the active parent
grant. They must be methods used to identify and quantify constituents (bioactive and other chemical marker constituents
and/or their metabolites, adulterants, or contaminants) in products intended for oral administration in humans or in
biological specimens such as urine, plasma, or animal tissues. As test agents the products studied may be investigated in
vitro or in vivo. The products under investigation in parent grants may be dietary supplements (including vitamins or
other bioactive compounds), foods, and other orally administered natural products or their raw source materials.
http://grants.nih.gov/grants/guide/pa-files/PA-13-381.html
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R01)
Funding Opportunity Number: (PAR-13-379)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: The goal of this funding opportunity announcement is to support the development of well-founded outcome
measures, including establishing their reliability and validity, for clinical studies of oral and craniofacial diseases and
conditions. http://grants.nih.gov/grants/guide/pa-files/PAR-13-379.html
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R21)
Funding Opportunity Number: (PAR-13-380)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Description: The goal of this funding opportunity announcement is to support the development of well-founded outcome
measures, including establishing their reliability and validity, for clinical studies of oral and craniofacial diseases and
conditions. http://grants.nih.gov/grants/guide/pa-files/PAR-13-380.html
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